ARCHIVES

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981

Alexion In Collaboration With Netherlands Center.

November 30, 2001

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014